Bisphenol-A impairs synaptic formation and function by RGS4-mediated regulation of BDNF signaling in the cerebral cortex

Dis Model Mech. 2022 Jul 1;15(7):dmm049177. doi: 10.1242/dmm.049177. Epub 2022 Jul 25.

Abstract

Bisphenol-A (BPA) is a representative endocrine disruptor, widely used in a variety of products including plastics, medical equipment and receipts. Hence, most people are exposed to BPA via the skin, digestive system or inhalation in everyday life. Furthermore, BPA crosses the blood-brain barrier and is linked to multiple neurological dysfunctions found in neurodegenerative and neuropsychological disorders. However, the mechanisms underlying BPA-associated neurological dysfunctions remain poorly understood. Here, we report that BPA exposure alters synapse morphology and function in the cerebral cortex. Cortical pyramidal neurons treated with BPA showed reduced size and number of dendrites and spines. The density of excitatory synapses was also decreased by BPA treatment. More importantly, we found that BPA disrupted normal synaptic transmission and cognitive behavior. RGS4 and its downstream BDNF/NTRK2 pathway appeared to mediate the effect of BPA on synaptic and neurological function. Our findings provide molecular mechanistic insights into anatomical and physiological neurotoxic consequences related to a potent endocrine modifier.

Keywords: BDNF/NTRK2 signaling; Bisphenol-A; Dendritic spine; RGS4; Synaptic transmission.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain-Derived Neurotrophic Factor* / metabolism
  • Cerebral Cortex / metabolism
  • Dendritic Spines / metabolism
  • Endocrine Disruptors* / pharmacology
  • Endocrine Disruptors* / toxicity
  • Humans
  • Pyramidal Cells / metabolism

Substances

  • Brain-Derived Neurotrophic Factor
  • Endocrine Disruptors